Literature DB >> 31729133

Transforming the interpretation of significance in heart failure trials.

Muhammad Shahzeb Khan1, Simra Irfan2, Safi U Khan3, Mandeep R Mehra4, Muthiah Vaduganathan4.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31729133      PMCID： PMC7453939          DOI： 10.1002/ejhf.1668

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  12 in total

1.  Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Jonathan L Halperin; Glenn N Levine; Sana M Al-Khatib; Kim K Birtcher; Biykem Bozkurt; Ralph G Brindis; Joaquin E Cigarroa; Lesley H Curtis; Lee A Fleisher; Federico Gentile; Samuel Gidding; Mark A Hlatky; John Ikonomidis; José Joglar; Susan J Pressler; Duminda N Wijeysundera
Journal:  Circulation       Date:  2015-09-23       Impact factor: 29.690

2.  Contemporary cardiovascular device clinical trials (trends and patterns 2001 to 2012).

Authors:  Muthiah Vaduganathan; Ayman S Tahhan; Stephen J Greene; Anita A Kelkar; Vasiliki V Georgiopoulou; Andreas P Kalogeropoulos; Gregg C Fonarow; Mihai Gheorghiade; Javed Butler
Journal:  Am J Cardiol       Date:  2015-04-18       Impact factor: 2.778

3.  Reporting and Interpretation of Randomized Clinical Trials.

Authors:  Howard Bauchner; Robert M Golub; Phil B Fontanarosa
Journal:  JAMA       Date:  2019-08-27       Impact factor: 56.272

4.  New Guidelines for Statistical Reporting in the Journal.

Authors:  David Harrington; Ralph B D'Agostino; Constantine Gatsonis; Joseph W Hogan; David J Hunter; Sharon-Lise T Normand; Jeffrey M Drazen; Mary Beth Hamel
Journal:  N Engl J Med       Date:  2019-07-18       Impact factor: 91.245

Review 5.  Cardiovascular drug development: is it dead or just hibernating?

Authors:  Christopher B Fordyce; Matthew T Roe; Tariq Ahmad; Peter Libby; Jeffrey S Borer; William R Hiatt; Michael R Bristow; Milton Packer; Scott M Wasserman; Ned Braunstein; Bertram Pitt; David L DeMets; Katharine Cooper-Arnold; Paul W Armstrong; Scott D Berkowitz; Rob Scott; Jayne Prats; Zorina S Galis; Norman Stockbridge; Eric D Peterson; Robert M Califf
Journal:  J Am Coll Cardiol       Date:  2015-04-21       Impact factor: 24.094

6.  Evaluation of Lowering the P Value Threshold for Statistical Significance From .05 to .005 in Previously Published Randomized Clinical Trials in Major Medical Journals.

Authors:  Cole Wayant; Jared Scott; Matt Vassar
Journal:  JAMA       Date:  2018-11-06       Impact factor: 56.272

Review 7.  The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index.

Authors:  Michael Walsh; Sadeesh K Srinathan; Daniel F McAuley; Marko Mrkobrada; Oren Levine; Christine Ribic; Amber O Molnar; Neil D Dattani; Andrew Burke; Gordon Guyatt; Lehana Thabane; Stephen D Walter; Janice Pogue; P J Devereaux
Journal:  J Clin Epidemiol       Date:  2014-02-05       Impact factor: 6.437

8.  Unbelievable Folly of Clinical Trials in Heart Failure: The Inconvenient Truth About How Investigators and Guidelines Weigh Evidence.

Authors:  Milton Packer
Journal:  Circ Heart Fail       Date:  2016-04       Impact factor: 8.790

9.  Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.

Authors:  Scott D Solomon; John J V McMurray; Inder S Anand; Junbo Ge; Carolyn S P Lam; Aldo P Maggioni; Felipe Martinez; Milton Packer; Marc A Pfeffer; Burkert Pieske; Margaret M Redfield; Jean L Rouleau; Dirk J van Veldhuisen; Faiez Zannad; Michael R Zile; Akshay S Desai; Brian Claggett; Pardeep S Jhund; Sergey A Boytsov; Josep Comin-Colet; John Cleland; Hans-Dirk Düngen; Eva Goncalvesova; Tzvetana Katova; Jose F Kerr Saraiva; Małgorzata Lelonek; Bela Merkely; Michele Senni; Sanjiv J Shah; Jingmin Zhou; Adel R Rizkala; Jianjian Gong; Victor C Shi; Martin P Lefkowitz
Journal:  N Engl J Med       Date:  2019-09-01       Impact factor: 91.245

10.  Angiotensin-neprilysin inhibition versus enalapril in heart failure.

Authors:  John J V McMurray; Milton Packer; Akshay S Desai; Jianjian Gong; Martin P Lefkowitz; Adel R Rizkala; Jean L Rouleau; Victor C Shi; Scott D Solomon; Karl Swedberg; Michael R Zile
Journal:  N Engl J Med       Date:  2014-08-30       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.